Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis

Arthritis and Rheumatism
Gerrit JansenB A C Dijkmans

Abstract

To investigate whether interactions of sulfasalazine (SSZ) with reduced folate carrier (RFC), the dominant cell membrane transporter for natural folates and methotrexate (MTX), may limit the efficacy of combination therapy with MTX and SSZ in patients with rheumatoid arthritis. Human RFC-(over)expressing CEM cells of T cell origin were used to analyze the effect of SSZ on the RFC-mediated cellular uptake of radiolabeled MTX and the natural folate leucovorin. Moreover, both cells with and those without acquired resistance to SSZ were used to assess the antiproliferative effects of MTX in combination with SSZ. Transport kinetic analyses revealed that SSZ was a potent noncompetitive inhibitor of RFC-mediated cellular uptake of MTX and leucovorin, with mean +/- SD K(i) (50% inhibitory concentration) values of 36 +/- 6 microM and 74 +/- 7 microM, respectively. Consistent with the inhibitory interaction of SSZ with RFC, a marked loss of MTX efficacy was observed when MTX was coadministered with SSZ: up to 3.5-fold for CEM cells in the presence of 0.25 mM of SSZ, and >400-fold for SSZ-resistant cells in the presence of 2.5 mM of SSZ. Importantly, along with diminished efficacy of MTX, evidence for cellular folate depletion was obtaine...Continue Reading

References

Jan 1, 1978·The Journal of Clinical Investigation·J SelhubI H Rosenberg
Feb 15, 1992·The Biochemical Journal·J E BaggottR J Hine
Jan 1, 1985·Scandinavian Journal of Rheumatology·K A Grindulis, B McConkey
Nov 30, 1971·Annals of the New York Academy of Sciences·I D Goldman
Dec 17, 1981·The New England Journal of Medicine·C H HalstedT Tamura
May 1, 1983·Archives of Internal Medicine·G F Longstreth, R Green
Feb 1, 1993·Arthritis and Rheumatism·S L MorganG S Alarcón
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R Bertino
Oct 3, 1996·The New England Journal of Medicine·R GorlickJ R Bertino
Aug 1, 1996·Scandinavian Journal of Clinical and Laboratory Investigation·M Krogh JensenL Svendsen
Dec 1, 1996·Arthritis and Rheumatism·B N Cronstein
Jul 17, 1998·British Journal of Rheumatology·A C VerhoevenP Tugwell
Aug 17, 1999·Annual Review of Nutrition·F M Sirotnak, B Tolner
Nov 30, 2000·The New England Journal of Medicine·J M BathonB K Finck
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Jul 17, 2001·Annals of the Rheumatic Diseases·M CutoloR H Straub
Jul 18, 2001·Springer Seminars in Immunopathology·N Fathy, D E Furst
Sep 15, 2001·Annals of the Rheumatic Diseases·L M JansenB A Dijkmans
Oct 16, 2001·American Journal of Physiology. Cell Physiology·A RajgopalI D Goldman
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Dec 11, 2002·Journal of Internal Medicine·S Ardizzone, G Bianchi Porro
Mar 12, 2003·Biochemical Pharmacology·Jan Hendrik HooijbergGerrit Jansen
May 31, 2003·Nature Reviews. Drug Discovery·Josef S Smolen, Günter Steiner

❮ Previous
Next ❯

Citations

Mar 17, 2009·Rheumatology International·Bedriye Mermerci BaşkanHatice Bodur
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Monika Østensen, Luigi Raio
Jan 5, 2007·Nature Clinical Practice. Rheumatology·Joost W van der HeijdenGerrit Jansen
Jun 19, 2013·International Journal of Rheumatic Diseases·Kayo MasukoToshihiro Matsui
Apr 23, 2005·Infection and Immunity·Jing WangTerry W Wright
May 25, 2006·Arthritis Research & Therapy·Klaus P MacholdJosef S Smolen
Apr 25, 2009·Journal of the American Academy of Dermatology·Robert E KalbMark Lebwohl
Jul 31, 2007·Alimentary Pharmacology & Therapeutics·Z S HeetunC O'Morain
Jul 14, 2011·The Biochemical Journal·Hamid M Said
Jul 21, 2015·Drug Metabolism and Pharmacokinetics·Masashi KawamiMikihisa Takano
Oct 25, 2014·Therapeutic Advances in Musculoskeletal Disease·Megan L KrauseAshima Makol
Sep 3, 2013·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Pradeep Kumar, Snehashish Banik
Jul 13, 2004·Arthritis and Rheumatism·Bruce N Cronstein
Nov 1, 2008·Arthritis and Rheumatism·Joel M Kremer
Oct 4, 2005·Arthritis and Rheumatism·Josef S SmolenEdward Keystone
Jun 10, 2010·Expert Review of Gastroenterology & Hepatology·Laurie S Conklin, Maria Oliva-Hemker
Sep 13, 2019·Nature·Rutger D LuteijnDavid H Raulet
Oct 12, 2019·Nature Immunology·Baptiste Guey, Andrea Ablasser
Aug 23, 2020·Cells·Nefertiti MuhammadJiyeon Kim
Dec 1, 2018·Archives of Toxicology·M VidmarM Sollner Dolenc
Apr 26, 2019·Proceedings of the National Academy of Sciences of the United States of America·Michael D ArensmanChristina H Eng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.